Tim Willis

Tim has worked in Dry Eye for more than 15 years. In that time, he developed the Soothe XP artificial tear product currently marketed by Bausch and Lomb. He helped develop and license Systane Balance to Alcon. Most recently, he was the founder, inventor, and CEO of TearScience, a medtech company started to diagnose and treat Meibomian Gland Dysfunction, the leading cause of Dry Eye. During his tenure at TearScience he raised $134M in funding, approved 4 products for the diagnosis and treatment of evaporative dry eye and launched them in over 30 countries and obtained regulatory clearance in over 50 countries. TearScience was acquired by Johnson and Johnson. Tim holds a BS in Electro-Mechanical Engineering and is a fellow of the American Academy of Optometry.